Uzbekistan adopts 17 national Sustainable Development Goals
In particular, Uzbekistan intends to reduce poverty. Also, one of the goals of Uzbekistan is to strengthen food security, improve diet.
Public health & disease
Mayor of London announces £5 million funding for public water fountains
The Mayor or London, Sadiq Khan, has announced a £5 million fund to implement more public water fountains.
Paralyzed patients walk again with help from new, revolutionary pain stimulator
The new research shows that electrical stimulation of the spine can re-educate the body and help move the legs even though signals from the brain are cut off.
A team of US-based hospitals is launching a nonprofit drug company to combat high drug prices
Civica Rx is a joint effort by big names like Catholic Health Initiatives, HCA Healthcare, Intermountain Healthcare, Providence St. Joseph Health, the Mayo Clinic, SSM Health, and Trinity Health.
New research shows CBD found in cannabis can help people with psychosis
According to a new study from King’s College London (KCL), just one dose of CBD can reduce abnormal brain function in people with psychosis.
NYU School Of Medicine to pay tuition for all students
The school says it wanted to reduce the amount of debt students are saddled with after medical school and attract a more diverse class of students.
New therapy bot helps children with autism perfect their social skills
Robotics startup LuxAI has created QTrobot, a bot designed to help children with autism learn valuable social skills.
Research successfully transplant lab-grown lungs in pigs
Eventually, bioengineered lungs could replace donor ones altogether. And that could make the transplant waiting list a thing of the past.
Chinese citizens are using blockchain to warn each other of unsafe vaccines
By using the blockchain in this new way, Chinese citizens may have finally found a way to express themselves that’s beyond the government’s reach.
Promising HIV vaccine moves to wider human trials
The most promising candidate for an effective HIV vaccine in over a decade is moving to large-scale human trials